Literature DB >> 15120937

Meta-analysis of autologous bone marrow transplantation versus chemotherapy in adult patients with acute myeloid leukemia in first remission.

Itai Levi1, Itamar Grotto, Ronit Yerushalmi, Isaac Ben-Bassat, Ofer Shpilberg.   

Abstract

In the present study, we have conducted a meta-analysis comparing autologous bone marrow transplantation (ABMT) and intensive chemotherapy in adult acute myeloid leukemia (AML) patients in first remission. Combined results of the six appropriate randomised controlled studies indicate that ABMT had no advantage over chemotherapy or no further treatment concerning death rate (overall rate ratio (RR)-0.95, 95% CI, 0.81-1.11), while was superior to chemotherapy concerning event rate (overall RR--0.82, 95% CI, 0.71-0.94). In conclusion, ABMT did not improve survival but it improved event-free survival (EFS) when compared with chemotherapy or no further treatment in patients with AML in first complete remission.

Entities:  

Mesh：

Year:  2004        PMID： 15120937     DOI： 10.1016/j.leukres.2003.10.029

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


  10 in total

1.  T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis.

Authors:  Norbert-Claude Gorin; Myriam Labopin; Simona Piemontese; William Arcese; Stella Santarone; He Huang; Giovanna Meloni; Felicetto Ferrara; Dietrich Beelen; Miguel Sanz; Andrea Bacigalupo; Fabio Ciceri; Audrey Mailhol; Arnon Nagler; Mohamad Mohty
Journal:  Haematologica       Date:  2015-01-30       Impact factor: 9.941

Review 2.  Acute myeloid leukemia: when to transplant in first complete remission.

Authors:  Brian T Hill; Edward A Copelan
Journal:  Curr Hematol Malig Rep       Date:  2010-04       Impact factor: 3.952

3.  Autologous transplantation gives encouraging results for young adults with favorable-risk acute myeloid leukemia, but is not improved with gemtuzumab ozogamicin.

Authors:  Hugo F Fernandez; Zhuoxin Sun; Mark R Litzow; Selina M Luger; Elisabeth M Paietta; Janis Racevskis; Gordon Dewald; Rhett P Ketterling; Jacob M Rowe; Hillard M Lazarus; Martin S Tallman
Journal:  Blood       Date:  2011-03-17       Impact factor: 22.113

4.  Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Authors:  Arnon Nagler; Myriam Labopin; Norbert-Claude Gorin; Felicetto Ferrara; Miguel A Sanz; Depei Wu; Antonio Torres Gomez; Simona Lapusan; Giuseppe Irrera; Jose E Guimaraes; Aida Botelho Sousa; Angelo M Carella; Norbert Vey; William Arcese; Avichai Shimoni; Raanan Berger; Vanderson Rocha; Mohamad Mohty
Journal:  Haematologica       Date:  2014-05-09       Impact factor: 9.941

5.  Comparable outcomes between autologous and allogeneic transplant for adult acute myeloid leukemia in first CR.

Authors:  M Mizutani; M Hara; H Fujita; J Aoki; H Kanamori; K Ohashi; K Usuki; T Fukuda; T Chou; J Tanaka; Y Atsuta; A Takami
Journal:  Bone Marrow Transplant       Date:  2016-01-25       Impact factor: 5.483

Review 6.  Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.

Authors:  John Koreth; Richard Schlenk; Kenneth J Kopecky; Sumihisa Honda; Jorge Sierra; Benjamin J Djulbegovic; Martha Wadleigh; Daniel J DeAngelo; Richard M Stone; Hisashi Sakamaki; Frederick R Appelbaum; Hartmut Döhner; Joseph H Antin; Robert J Soiffer; Corey Cutler
Journal:  JAMA       Date:  2009-06-10       Impact factor: 56.272

7.  Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myelogenous leukemia: a study from the center for international blood and marrow transplantation research.

Authors:  James M Foran; Steven Z Pavletic; Brent R Logan; Manza A Agovi-Johnson; Waleska S Pérez; Brian J Bolwell; Martin Bornhäuser; Christopher N Bredeson; Mitchell S Cairo; Bruce M Camitta; Edward A Copelan; Jason Dehn; Robert P Gale; Biju George; Vikas Gupta; Gregory A Hale; Hillard M Lazarus; Mark R Litzow; Dipnarine Maharaj; David I Marks; Rodrigo Martino; Richard T Maziarz; Jacob M Rowe; Philip A Rowlings; Bipin N Savani; Mary Lynn Savoie; Jeffrey Szer; Edmund K Waller; Peter H Wiernik; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2013-04-28       Impact factor: 5.742

8.  Clinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: Practice Guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation.

Authors:  Enrica Morra; Giovanni Barosi; Alberto Bosi; Felicetto Ferrara; Franco Locatelli; Monia Marchetti; Giovanni Martinelli; Cristina Mecucci; Marco Vignetti; Sante Tura
Journal:  Haematologica       Date:  2008-11-10       Impact factor: 9.941

9.  Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Intermediate-Risk Acute Myeloid Leukemia Adult Patients in First Complete Remission: A Meta-Analysis of Prospective Studies.

Authors:  Dandan Li; Li Wang; Honghu Zhu; Liping Dou; Daihong Liu; Lin Fu; Cong Ma; Xuebin Ma; Yushi Yao; Lei Zhou; Qian Wang; Lijun Wang; Yu Zhao; Yu Jing; Lili Wang; Yonghui Li; Li Yu
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

10.  Bone marrow transplantation and acute myeloid leukemia: Brazilian guidelines.

Authors:  Lucia Mariano da Rocha Silla; Frederico Dulley; Rosaura Saboya; Eduardo Paton; Fabio Kerbauy; Adriano de Moraes Arantes; Nelson Hamerschlak
Journal:  Rev Bras Hematol Hemoter       Date:  2013
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.